Contact
Please use this form to send email to PR contact of this press release:
Ichor Life Sciences Inc. Announces the Opening of Phase I-IV Clinical Trial Facility in Syracuse, NY
TO:
Lisa Sonneborn, President of Ichor Research
Ichor Research
315-263-3997